Home › Funds › Point72 Asset Management › RPRX
Point72 Asset Management position in RPRX
ROYALTY PHARMA PLC · Health Care
Latest position (Q2 2026)106.55K sh
Reported value held$5.97M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 59.10K | $2.14M | New |
| Q4 2021 | 336.10K | $13.39M | Add |
| Q1 2022 | 1.89M | $73.75M | Add |
| Q1 2023 | 618.80K | $22.30M | New |
| Q2 2023 | 530.20K | $16.30M | Reduce |
| Q3 2023 | 728.20K | $19.76M | Add |
| Q4 2023 | 1.17M | $32.83M | Add |
| Q1 2024 | 521.20K | $15.83M | Reduce |
| Q3 2024 | 526.63K | $14.90M | New |
| Q4 2024 | 249.00K | $6.35M | Reduce |
| Q1 2025 | 318.50K | $9.91M | Add |
| Q2 2025 | 318.50K | $11.48M | Hold |
| Q3 2025 | 298.30K | $10.52M | Reduce |
| Q4 2025 | 534.31K | $20.65M | Add |
| Q1 2026 | 490.02K | $23.51M | Reduce |
| Q2 2026 | 106.55K | $5.97M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RPRX
- Morgan Stanley 42.93M sh · $2.41B · Q2 2026
- BlackRock Inc 27.83M sh · $1.56B · Q2 2026
- Fidelity Management & Research (FMR) 24.51M sh · $1.37B · Q2 2026
- Baillie Gifford & Co 10.02M sh · $561.57M · Q2 2026
- Capital World Investors 9.52M sh · $533.64M · Q2 2026
- Geode Capital Management 8.06M sh · $450.58M · Q2 2026
- Vanguard Group 9.93M sh · $383.87M · Q4 2025
- Norges Bank Investment Management 5.34M sh · $299.19M · Q2 2026
- Northern Trust Corp 4.72M sh · $264.59M · Q2 2026
- AQR Capital Management 4.31M sh · $241.40M · Q2 2026
- Invesco Ltd 4.23M sh · $237.32M · Q2 2026
- Bank of America Corp 4.15M sh · $232.66M · Q2 2026